Kyle Boyar

University of California, San Diego | UCSD · Skaggs School of Pharmacy and Pharmaceutical Sciences / Center for Medicinal Cannabis Research (CMCR)

Link to the full Emerald Conference 2020 Presentation: https://vimeo.com/442500870 The State of California’s roll out of heavy metal testing on January 1, 2019 sent cannabis vape cartridge manufacturers into a state of panic when many quickly realized that the hardware being used would not pass Phase III compliance testing. In the absence of rigor...

The use of cannabis for animal species is an area of growing interest, largely due to the therapeutic benefits being observed for humans and animals in the era of cannabis legalization. The close relationship humans have with their pets and other veterinary species has led to a renewed interest in the possibility and promise of cannabis to treat si...

Even in the year 2020, the majority of well-established analytical laboratories are utilizing paper documents and excel spreadsheets to generate and compile data. While it is possible to run a lab with these basic tools, it makes it subsequently very difficult to scale up operations when operational efficiency is tied to pen and paper. Additionally...

Cannabinoid pharmacokinetics is something that is far from straightforward as evidenced in this 2012 study. I covered this paper for the Cannabis Chemistry Subdivision of DCHAS at ACS journal club about a year ago but unfortunately we had issues with our Zoom meeting platform that day and it was not recorded. What's particularly important about t...

The cannabis plant and cannabis products are highly varied and complex matrices with each different product and route of administration having its own considerations for microbial testing. In the absence of rigorous study, this immature industry has decided to adopt methods commonly used in food testing to obtain information about the potential mic...

The microbial testing of cannabis and cannabis products presents a unique set of challenges. Unlike food testing, cannabis testing has various routes of administration to take into account. Cannabis flowers express high levels of antimicrobial cannabinoids and terpenoids and thus represent a different matrix than traditional foods. It is currently...

Describes the use of DNA sequencing coupled with blockchain technology as a mechanism for demonstrating prior art for cannabis intellectual property.

I wrote this in 2016 after becoming curious about how cannabis can induce creative states. It ended up becoming the topic of an episode of the podcast SmartDrugSmarts (https://smartdrugsmarts.com/episodes/221-marijuana-the-non-medical-kind/). I never published it or truly finished it - but at some point I may revisit this and revamp with new rese...

A short article I wrote in 2014 about the potential of cannabinoids in Leaky Gut Syndrome and how the endocannabinoid system can be used as a therapeutic target to treat this condition.

A short article I wrote in 2014 about the potential of cannabinoids for the treatment of migraines.